The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...
Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...
Participants began with an average HbA1c level of 8.1%. After three months, people who used Omnipod 5 improved HbA1c by an ...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...
Across the UK and Ireland in recent years, there has been an increase in kids becoming seriously ill soon after drinking ...
Ramadan, the ninth month of the Islamic lunar calendar, is a period of fasting, prayer, reflection, and community for Muslims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback